FDA 510(k)
FDA class 2
Substantially Equivalent
🇬🇧 United Kingdom
CamAPS FX
K Number: K232603
·
Decision May 23, 2024
Classifications
1
FEI Numbers
13
Registration Numbers
13
Same Product Code
19
Applicant Total
1
Review Days
269
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- CamAPS FX
- K Number
- K232603
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.1356
- Medical Specialty
- Clinical Chemistry
- Decision
- Substantially Equivalent
- Statement or Summary
- Statement
- Applicant
- Camdiab , Ltd.
- Date Received
- August 28, 2023
- Decision Date
- May 23, 2024
- Product Code
- QJI
- Advisory Committee
- Clinical Chemistry
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| QJI | Interoperable Automated Glycemic Controller | FDA class 2 | Clinical Chemistry |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (QJI), ordered by most recent decision date.
Control-IQ+ technology
FDA 510(k)
FDA Class 2
·Clinical Chemistry
SmartGuard Technology; Predictive Low Glucose Technology
FDA 510(k)
FDA Class 2
·Clinical Chemistry
SmartGuard technology; Predictive Low Glucose technology
FDA 510(k)
FDA Class 2
·Clinical Chemistry
DBLG2
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Omnipod 5 algorithm
FDA 510(k)
FDA Class 2
·Clinical Chemistry
SmartGuard technology; Predictive Low Glucose technology
FDA 510(k)
FDA Class 2
·Clinical Chemistry